전도계 구조와 기능, 12유도 심전도 판독

서맥성 부정맥 심전도

Narrow QRS Tachycardia 감별

Wide QRS Tachycardia 감별

ECG from Wearable Devices, Telemonitor

Discussion

Clinical Phenotypes and Use of Artificial Intelligence

Discussion

Racial and Sex Differences in Characteristics and Outcomes of HFpEF

Discussion

Therapeutic Approaches to Cardiometabolic Phenogroups in HFpEF

Discussion

Therapeutic Approaches to Atrial Fibrillation in HFpEF

Discussion

Session Discussion

Effect of GLP-1R Agonists beyond Weight Control for ASCVD Protection

SGLT2 Inhibitors beyond Glucose Control: Cardio-Renal Protection

Targeting Aldosterone and Mineralocorticoid Receptors: A Game-changer in Cardio-Renal Disease

Endothelin Pathway Blockade: A New Frontier in Cardio-Renal Syndromes

Discussion

HCM： An Overview with a Focus on Epidemiology, Genetics, and Differential Diagnosis

Multimodality Assessment of HCM： Role of CMR, Holter, Stress Test, and More

Mavacamten: A Digest of Cinical Trials & Tips and Tricks for Its Use

Surgical Myectomy: Present and Future, with Translation into Contemporary HCM Management

Discussion

PCSK9 Deficiency Protects against Myocardial Infarction via Increasing Atrial Natriuretic Peptide

Microbiome and Cardiometabolic Disease

Resistin Regulates Inflammation and Insulin Resistance in Humans via the Endocannabinoid System

Spatiotemporal Immune Modulation to Reverse Post-MI Cardiac Remodeling

Discovery of Biomarkers for Predicting Treatment Responsiveness in Acute Myocardial Infarction Msc Therapy: Towards Next-Generation Stem Cell Therapeutics

Discussion

Role of Genetic Testing in Pediatric Cardiovascular Diseases: Indications,Interpretation,and Clinical Impact

Hereditary Cardiomyopathies in Adults: Advances in Understanding,Diagnosis,and Treatment

Molecular Autopsy in Forensics Focused on THE HEART

Discussion

Comorbidity and Risk Factor Management of AF: Obesity, Obstructive Sleep Apnea, and Physical Inactivity

Optimal Dosing Strategies of Non-Vitamin K Antagonist Oral Anticoagulants for Asian Patients with AF

Management of Atrial Tachycardia after Pulmonary Vein Isolation

Wearable Devices for AF Monitoring: Differential Risk Factors for Asymptomatic vs. Symptomatic AF

Current Status of Factor XIa Inhibitors for Stroke Prevention in AF

Discussion

Vericiguat for HFrEF

Discussion

Finerenone for HFpEF

Discussion

Semaglutide/Trizepatide for HFpEF

Discussion

Mavacamten for oHCM

Discussion

Session Discussion

Expanding Beyond LDL-C: Integrating Novel Targets in Atherogenic Dyslipidemia Management

Challenges in Hypertriglyceridemia therapy: Lessons from RCTs

CETP Inhibition Revisited: Shifting Focus from HDL-C to LDL-C in the Battle Against Atherosclerosis

Lipoprotein(a): The Silent Contributor to Atherosclerosis and Its Growing Clinical Significance

Discussion

Evolving Classification and Pathophysiology of MR

Measurement and Interpretation of MR Severity: Challenges and Solutions

Role of Multimodality Imaging in MR

Patient Selection for Transcatheter MV Repair and Replacement: Case? based Learning

Discussion

Cardiac Electrophysiology: Patch Clamp and Multielectrode Array

Cardiac Contractility: Pressure-volume Loop Analysis Using Langendorff Technique, and Single Cardiomyocyte Contraction Analysis (IonOptix)

Cardiac Metabolism: Mitochondria Assay and Metabolomics

Cardiac Histopathology

Cardiac Single Cell Sequencing

Discussion

상급종합병원 구조전환의 방향과 정책적 과제

효율적인 심장혈관 중환자실 운영을 위한 병원의 방안

심장 중환자 치료의 최신 지견과 현실의 문제점

Discussion

Optimal Approach for HMOD Management with Fimasartan Combination Therapy

Benefits of Aspirin/Rabeprazole Combination Therapy for CV Protection

Why Cardiologists Should Consider Shingles Prevention for Patients with Cardiovascular Diseases

Recent Trends and Clinical Evidence for Optimizing Lipid Management

Reaching LDL-C Targets in Patients at High Risk: How Well Are We Doing?

ACT NOW ADD Evolocumab to Reduce CV Risk in ASCVD Patients

What Makes Evolocumab Different to Reduce CV Risk in ASCVD Patients?

Discussion

The Benefit of Clopidogrel Over Aspirin after DAPT for CAD Patients Undergoing PCI

Personalized Anticoagulation Therapy: Balancing Efficacy and Safety in High-Risk Patients

Safety and Efficacy of Moderate-Intensity Statin with Ezetimibe in Elderly Patients with Atherosclerotic Cardiovascular Disease

故 서순규 교수님 소개 및 묵념

Revisiting Chronic Coronary Syndromes in 2025: Redefining Diagnosis and Management

Discussion

Risk Stratification of SCD by Genetic Analysis in Hypertrophic Cardiomyopathy

Catheter Ablation of PVC and Focal VT Not from Right Ventricular Outflow Tract

Substrate Mapping and Local Activation Time Mapping of VT

Idiopathic Left Ventricular Tachycardia: Trans-aortic Vs. Trans-septal Approach

SCD Risk Stratificagtion by AI-based ECG Analysis

Discussion

Pharmacologic Management

DAPT(Dual Antiplatelet Therapy) or SAPT(Single Antiplatelet Therapy): That Is the Question?

What Is the Optimal GDMT(Guideline Directed Medical Therapy) in AMI?

Discussion

Preventive Management: Beyond LDL-C

Lp(a),TRL,Apolipoproteins: What Is the New Therapeutic Target to Reduce Residual Risk?

Role of Inflammation on AMI: Monitoring and Management

Discussion

말초동맥질환은 어떻게 진단하는가? (병력,기능검사,영상검사)

말초동맥질환에 진짜 도움이 되는 약물과 도움이 안되는 약물은 무엇인가?

말초동맥질환에서의 항혈전제치료, 무엇을 어떻게 언제까지 처방해야 하는가?

말초동맥질환에서 고압산소치료와 줄기세포 치료의 허와 실은 무엇인가?

말초동맥질환에서의 운동치료 (심장재활치료)는 진짜로 도움이 되는가? 어떻게 하는가?

Discussion

Coronary Physiology in Women

Sex Differences in Coronary Spasm

INOCA and MINOCA in Women

Sex differences in Coronary Dissection

Stress Cardiomyopathy: Gender-Specific Considerations

Discussion

The Outcome of Aortic Valve and Ascending Aorta in TGA after ASO: What Do We Know Until Now?

The Outcome of Aortic Arch and Descending Aorta in TGA after ASO: Is It Really No Problem after ASO?

The Outcome of RVOT and Branch Pulmonary Arteries in TGA after ASO

The Outcome of Coronary Arteries and Myocardium in TGA after ASO

The Outcome of Exercise Capacity in TGA after ASO

Discussion

필수의료 (심장 혈관 질환) 수가보상 개선사업

심장 혈관 질환 수가 보상에 대한 제언

Discussion

상급종합병원 구조전환에서 심장 혈관 질환군의 역할

심장 혈관 질환 중증분류 개선방안

Discussion

The Diagnostic Approach to Myocarditis: The Role of Multimodality Imaging Based on Current Guidelines

Emerging Critical Disease: Immune Checkpoint Inhibitor-Associated Myocarditis in Cancer Patients

Echocardiography as the Most Important Primary Diagnostic Tool of Myocarditis

Enhancing Myocarditis Diagnosis: The Power of CMR in Tissue Characterization

Evolving of Nuclear Imaging: Advancements in the Diagnosis and Treatment Evaluation of Myocarditis

Discussion

Best Timing in AMI Procedure: Is the Story Complete?

What Is the Best Timing to Revascularize AMI with Acute Decompensated HF: Now or Later?

What Is the Best Timing of MCS(Mechanical Circulatory Support) in AMI with Cardiogenic Shock?

Discussion

Unusual Cause of AMI: Case-based Learning from the Expert

My Personal Algorithm for SCAD(Spontaneous Coronary Artery Dissection): Diagnosis and Management

My Personal Algorithm for MINOCA(Myocardial Infarction with Non-obstructive Coronary Artery Disease): Diagnosis and Management

Discussion

Effects of Complete Revascularization in Patients with Acute Myocardial Infarction

Identification of Non-culprit Lesions that Require PCI in STEMI

Identification of Culprit Lesions in NSTEMI

Optimal Timing for Complete Revascularization

Non-atherosclerotic Causes of STEMI

Discussion

Shaping the Future of AI-Driven Cardiology

Al-diven Innovation of Coronary Angiography

AI-driven Innovation of ECG

AI-driven Innovation of Cardiovascular Risk

AI-driven Innovation of Robotics

Discussion

Mavacamten(Camzyos) and Recent Trend of Treatment in Adult HCM(Hypertrophic Cardiomyopathy)

Sotatercept (Winrevair) and Recent Trend of Treatment in Adult PH(Pulmonary Hypertension)

Semaglutide (Wegovy) and Other Novel Medical Treatments in Heart Failure - Are They Have Benefits in ACHD Patients?

Resent Update of EPS and RFCA in Adult Patients with PVC

Preparation of Transcatheter Tricuspid Valve Intervention

Discussion

Role of Ambulatory Blood Pressure Monitoring in Clinical Practice

Limitations of Ambulatory Blood Pressure Monitoring

Equating Office and Ambulatory Blood Pressure

Recent Innovations in Ambulatory Blood Pressure Devices

Future Research Directions on Hypertension Using Ambulatory Blood Pressure Monitoring

Discussion

Unraveling the Secrets: How Microcirculation and Lymphatics Regulate Our Body

Lymphatic Reserve Depletion and Its Impact on Cardiovascular Health?

Chronic Venous Insufficiency: Risk Factors and Diagnosis

Navigating the Dilemma of Subclinical Venous Thrombosis

Harnessing Exercise and Physical Therapy in VTE Management

Discussion

Air Pollution and Cardiovascular Diseases: Epidemiologic Findings

Impact of Microplastic Exposure on Vascular Health and Atherosclerosis

Comparison of Thrombus, Gut, and Oral Microbiomes in Korean Patients with ST-Elevation Myocardial Infarction: A Case?control Study

Psychosocial Stress and Atherosclerosis: Mechanisms and Clinical Implications

Discussion

Etiology and Mechanism of CS Associated with RV Failure

Comprehensive Assessment of CS Associated with RV Failure

Hemodynamic Management of CS Associated with RV Failure

My Best and Worst Case of CS Associated with RV Failure

Discussion

Optimizing Physical Activity: Evidence-Based Strategies for CVD Prevention

Dietary Patterns for Cardiovascular Health: What Works Best?

Sleep and Cardiovascular Health: Why It Matters

Digital Therapeutics and Neuromodulation for Psychology-based CVD Prevention

Discussion

What Are the Secondary Findings from Genetic Test?

Cardiomyopathy Related Genes

Arrhythmia Related Genes

Aortopathy Related Genes

Discussion

Cancer Treatment as a Possible Risk Factor for Cardiovascular Disease in Cancer Survivors

Cardiovascular Risk Stratification in Pediatric and Adolescent Cancer Survivors

Survivorship in Adult Hematologic Malignancies

Physical Activity and Cardiovascular Risk in Cancer Survivors

Discussion

Fibromuscular Dysplasia: An Evolving Understanding of a Rare Vascular Disease: Genetics and Global Epidemiology

Diagnostic Advances in Fibromuscular Dysplasia: Imaging and Beyond

Fibromuscular Dysplasia and Arterial Hypertension: Pathophysiological Insights

Management Strategies for Fibromuscular Dysplasia: From Medications to Interventions

Future Directions in Fibromuscular Dysplasia Research and Treatment Innovations

Discussion

Cutting-Edge Drug Delivery Approaches to Vascular Disease: Gene, Ligand, and Therapeutics

Unmasking Lipoprotein(a): A Hidden Player in Cardiovascular Risk

Beyond LDL: The Role of Triglyceride-Rich Lipoproteins in Residual Cardiovascular Risk

The Emerging Role of Apolipoproteins in Cardiovascular Medicine: Biomarkers and Therapeutic Potential

Discussion

Radiology and AI Perspective: AI-driven Imaging for Sarcopenia: Focusing on Muscle Mass and Quality Assessment

Endocrinology Perspective: Cardiometabolic Drivers of Sarcopenia and Frailty: From Insulin Resistance to Osteosarcopenia

Neurology Perspective: Sarcopenia, Frailty, and Cognitive Decline: Shared Mechanisms and Early Detection

Exercise Physiology Perspective: Targeting Sarcopenia in Cardiometabolic Disease: Personalized Exercise Strategies for Prevention and Management

Nutrition Perspective: Optimizing Nutrition for Muscle Health: Protein, Amino Acids, and the Role of Metabolic Modulation

Discussion

Surgery after Failed TAVR: Indications & Outcomes

Techniques & Pitfalls for Explantation of Transcatheter Valves

Surgery after Failed TEER: Considerations & Outcomes

Surgery after CAVAR: Surgical Options and Techniques

Discussion

Understanding the Embryology and Anatomy of Ebstein Anomaly

Advanced Imaging in Ebstein Anomaly: Deciding When Surgical Referral Is Necessary

Arrhythmias in Ebstein Anomaly: Risk Assessment and Management

Neonatal and Infantile Ebstein Anomaly: A Guide to Managing Severe Cases

Surgical Strategies and Long-Term Outcomes in Ebstein Anomaly

Discussion

How Should We Interpret the Genomic Test Report of Cardiac Disease Patients?

Obstructive HCMP: Diagnosis and Cases of Mavacamten Application

DCMP: Critical Genes You Must Know

Restrictive CMP: TTR Amyloidosis, Diagnosis and Therapy

Diagnosis and Management of Cancer Therapy-related Cardiac Dysfunction

Discussion

Managing LDL-C: Reducing Visit-to-Visit Variance with Inclisiran

Discussion

Optimal Comorbidity Management for CV Protection in Hypertensive Patients with Dyslipidemia

Strategic Anti-platelet Therapy from Primary to Secondary Cardiovascular Disease Prevention

The Latest Evidence-Based Insights on LDL-C Lowering Strategies with Atorvastatin/Ezetimibe Combination Therapy

Treatment of Hypertension with LVH: Key Studies and Clinical Insights on Cozaar

Strategy for Perfect 24hr BP Control

Intensive Treatment Strategy in Hypertension

Beta-blocker Therapy in Patients with AMI: Are All β-blockers the Same?

The Need for Low-Dose Statins: Clinical Benefits of Atorvastatin 5mg

HFpEF and Empagliflozin: A Paradigm Shift in Cardiology

Empagliflozin in HFrEF: Practical Approach and Tips on the "Fantastic Four"

One Point Up: Consideration of Renal Safety in Dyslipidemia Patients with Cardio-renal Risks

Two Point Up: Importance of Renal Safety in Dyslipidemia Patients with DM

The Pioneering Inpatient Telemonitoring Systems, thynC

Optimizing Hypertension Treatment with Olmesartan: BP Control & CV Protection?

Cutting Edge Care of Pitavastatin with Ezetimibe Combination Therapy

Is There a Better Treatment Option for Dyslipidemia Patients with Impaired Glucose Metabolism

Efficacy & Safety of Very High-power Short-duration Ablation: Pulmonary Vein Isolation & Beyond Pulmonary Vein

ICE or 3D Mapping System Guided Fluoroless AF ablation

Evolving Evidence on Catheter Ablation of AF in Patients with HFrEF

Utility of Cavo-tricuspid Isthmus, Superior Vena Cava, and Vein of Marshall Ablation for Persistent AF

Safety Considerations with PFA: Coronary Artery Injury, Hemolysis and Cerebral Lesions

Discussion

Before Discharge for Heart Failure Hospitalization

Discussion

In Patients with Hypotension and Worsening Renal Function

Discussion

In Young Patients with Poor Compliance

Discussion

In Elderly Patients with Frailty and Cognitive Impairmenet

Discussion

Session Discussion

Invasive Physiology: Hyperemic & Nonhyperemic Pressure Ratios

Angiography Derived FFR

CT Based Physiology

Post-PCI Physiology

Evaluation of Microvascular Dysfunction

Discussion

One More Dimension, Endless Possibilities: The Impact of 3D Echocardiography on Structural Heart Disease Management

Speckle-Tracking Echocardiography as a Clinical Staple with Case-Specific Impact

Illuminating the Unexpected: How Contrast Echocardiography Changes the Game in Certain Cases

Stress Echocardiography: Unmasking Hemodynamic Clues for Clinical Decision-Making

Discussion

Cardiovascular Complication and Lifelong Management Strategies in Patients with Down Syndrome

Cardiovascular Complications and Management in CATCH22 Syndrome

Update on Cardiovascular Outcome and Management in Patients with RAsopathy Including Noonan Syndrome

Advances in Indications and Outcomes of Cardiovascular Interventions in Williams Syndrome

Perioperative Consideration of Patients with Malformation Syndrome

Discussion

Current Status of Antiarrhythmic Therapy in SVT

Current Status of Antiarrhythmic Therapy in AF and SCAF

Current Status of Antiarrhythmic Therapy in Ventricular Arrhythmias

Neuromodulation of Cardiac Arrhythmias

Novel Antiarrhythmic Therapy in the Near Future

Discussion

The Shift Towards Physiologic Pacing: A Paradigm Change

Biventricular Pacing vs. Conduction System Pacing: Advancing Heart Failure Therapy

Recent Advances in Leadless Pacing

Physiologic Atrial Pacing: Is It Feasible and Truly Necessary?

Unresolved Challenges and Future Perspectives: Shaping the Path Forward

Discussion

Overviews of Genetic Basis and Diverse Etiologies

Discussion

Fulminant Myocarditis

Discussion

Immune Checkpoint Inhibitor Myocarditis

Discussion

Endomyocardial Biopsy from A to Z

Discussion

Session Discussion

Korea Is Falling behind in TAVR Practices: Expanding to Low Risk and Younger Patients

Identifying Patients at Risk of Futile Outcomes Following TAVR

Cerebral Embolic Protection Devices: Expectations and Reality

Suicide Left Ventricle after TAVR: Risk Assessment and Management Strategies

Follow-up and Management of Subclinical Leaflet Thrombosis after TAVR

Discussion

Basics of Pericardial Diasease: Anatomy, Physiology, and Assessment

Managing Pericardial Effusion: Deciding When and How to Drain

Post-Pericardiotomy Syndrome: Recognizing and Addressing an Unwanted Complication

When the Surrounding Wall Becomes Too Stiff: Strategies for Managing Constrictive Pericarditis

Discussion

의료윤리 관점에서의 의사결정을 위한 팀워크와 리더십

중환자의 연명치료 중단에 대한 윤리적 고찰

과학, 의학 그리고 윤리

출판 윤리의 최신 지견: 약탈적 저널-학회 피하기

From Diagnosis to Closure: ASD/PFO/PDA

Essential Techniques and Practices of M-TEER

Recent Update of TAVR

Stroke Prevention beyond Anticoagulation: LAAO

ICE for Structural Heart Disease

Discussion